References
1. Gillard, J., Ford-Hutchinson, A. W., Chan, C., Charleson, S., Denis, D., Foster, A., Pacholok, S. (1989). L-663,536 (MK-886)(3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2, 2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Canadian journal of physiology and pharmacology, 67(5), 456-464. 2. Khan, M. A., Hoffbrand, A. V., Mehta, A., Wright, F., Tahami, F., Wickremasinghe, R. G. (1993). MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Leukemia research,17(9), 759-762. 3. Dittmann, K. H., Mayer, C., Rodemann, H. P., Petrides, P. E., Denzlinger, C. (1998). MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells. Leukemia research, 22(1), 49-53.USBio References
No references available